Wed, Sep 17, 2014, 2:44 PM EDT - U.S. Markets close in 1 hr 16 mins

Recent

% | $
Quotes you view appear here for quick access.

Hyperion Therapeutics, Inc. (HPTX) Message Board

vvvvvvrebel89130 1547 posts  |  Last Activity: 8 minutes ago Member since: Sep 15, 2008
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • vvvvvvrebel89130 by vvvvvvrebel89130 Sep 8, 2014 5:19 PM Flag

    gl longs

    Sentiment: Strong Buy

  • Reply to

    $16.70-18

    by hockeykd19 Sep 8, 2014 1:12 PM
    vvvvvvrebel89130 vvvvvvrebel89130 Sep 8, 2014 2:47 PM Flag

    vol picking up steam; could get interesting

    Sentiment: Strong Buy

  • Short Sale Circuit Breaker

    The SEC adopted amendments to Regulation SHO with a compliance date of November 10, 2010. Among the rule changes, the SEC introduced Rule 201 (Alternative Uptick Rule), a short sale-related circuit breaker that when triggered, will impose a restriction on prices at which securities may be sold short. The SEC also issued guidance for broker-dealers wishing to mark certain qualifying orders 201cshort exempt.201d For more details, refer to Amendments to Regulation SHO (Release 34-61595).

    Trade Date Download Link File Creation Timestamp
    Monday, September 8,2014
    Download
    9/8/2014 4:15:04 AM
    Symbol Security Name Market Category Trigger Time
    REPH Recro Pharma, Inc. R 9/5/2014 9:30:00 AM
    ZUMZ Zumiez Inc Q 9/5/2014 9:30:00 AM
    CMCT CIM Commercial Trust Corp Q 9/5/2014 9:31:50 AM
    PLNR Planar Systems Inc Q 9/5/2014 9:35:18 AM
    VPCO Vapor Corp. Common Stock R 9/5/2014 9:39:38 AM
    CISAW CIS Acq. Ltd. Warrant R 9/5/2014 9:40:30 AM
    ACHN Achillion Pharmaceuticals Q 9/5/2014 9:45:09 AM
    MBII Marrone Bio Inn

    Sentiment: Strong Buy

  • Reply to

    Shares and shorts RIGHT INFO

    by bikerieder61 Sep 8, 2014 12:52 PM
    vvvvvvrebel89130 vvvvvvrebel89130 Sep 8, 2014 12:58 PM Flag

    thanks; do you know what the conditions are for converting the preferred? 21k converts into 5.6mm!!
    that's one heck of a ratio, lol

    Sentiment: Strong Buy

  • vvvvvvrebel89130 vvvvvvrebel89130 Sep 8, 2014 12:36 PM Flag

    someone else agrees with you; check out the oct 15 calls

    15.00 ACHN141018C00015000 1.45 Up 0.45 1.35 1.45 3,922 3,557

    Sentiment: Strong Buy

  • Reply to

    Short Interest 21.93%...

    by dmorfey Sep 8, 2014 7:31 AM
    vvvvvvrebel89130 vvvvvvrebel89130 Sep 8, 2014 12:30 PM Flag

    per yahoo, 52mm shrs o/s; per nasdaq, 'tute ownership is 42mm shrs; per nasdaq, short interest is 11.6mm shrs

    so the float is 10mm shrs, but the actual float is probably 7-8mm shrs with shrs held by longs

    so you hve a stock with a tradeable float of 7mm shrs with 11.6mm shrs short

    very interesting dynamic

    Sentiment: Strong Buy

  • vvvvvvrebel89130 by vvvvvvrebel89130 Sep 8, 2014 11:13 AM Flag

    40k and 20k +

    Sentiment: Strong Buy

  • reason for the rape on friday and rally today

    Sentiment: Strong Buy

  • vvvvvvrebel89130 by vvvvvvrebel89130 Sep 8, 2014 10:28 AM Flag

    plowed right thru them

    Sentiment: Strong Buy

  • vvvvvvrebel89130 vvvvvvrebel89130 Sep 6, 2014 7:09 PM Flag

    the takedown/shakedown/rape occurred 2 days after the fbr 1-1's

    still say someone heard something very positive on wednesday as evidenced by wednesday and friday's trading

    Sentiment: Strong Buy

  • Reply to

    Ach-3422 NewZealand Trial

    by macugen_rules Sep 5, 2014 10:47 PM
    vvvvvvrebel89130 vvvvvvrebel89130 Sep 6, 2014 12:46 AM Flag

    i think this guy knows more about the trial than macweenie

    More on Professor Gane who is the principal investigator for all recent and ongoing Achillion trials, including the 3422 trial --

    "ED GANE, MBCHB, MD, FRACP, MNZM

    Gane, Ed 2014New Zealand Liver Transplant Unit, Auckland City Hospital, New Zealand

    Dr. Gane is Professor of Medicine at the University of Auckland, New Zealand and Chief Hepatologist, Transplant Physician and Deputy Director of the New Zealand Liver Transplant Unit at AucklandCityHospital.

    Dr. Gane trained in hepatology at the Institute of Liver Studies, King’s College School of Medicine, London, where he completed his MD on the pathogenesis of hepatitis C-related liver allograft injury following transplantation for HCV-cirrhosis.

    In 1998, Dr. Gane was appointed as Chief Transplant Physician for the first New Zealand Liver Transplant programme at Auckland City Hospital. In addition, Dr. Gane runs large Hepatitis Clinics in Auckland and GreenlaneHospitals for patients and a large tertiary Liver Cancer Clinic.

    In 2000, Dr. Gane became the Ministry of Health Clinical Advisor for the National Hepatitis B Screening and Follow-up Programme. In 2013, Dr. Gane was appointed as Hepatitis C Champion for the Ministry of Health National Hepatitis C Project.

    Dr. Gane is an Investigator for many international clinical trials of therapies for chronic viral hepatitis with particular interest in early phase development of new direct acting antiviral therapies against hepatitis C and hepatitis B. Dr. Gane has published almost 150 papers in peer-reviewed journals including The Lancet and The New England Journal of Medicine and serves on the editorial committee for several journals. Dr. Gane serves on the Executive Committee of the NZ Society of Gastroenterology and is a member of several international organisations including APASL, AASLD, ILCA and ILTS.

    In May 2011, Dr. Gane was awarded Member of the Order of New Zealand for Services to Medicine"

    Sentiment: Strong Buy

  • Reply to

    I need double helixx

    by macugen_rules Sep 5, 2014 6:14 PM
    vvvvvvrebel89130 vvvvvvrebel89130 Sep 5, 2014 10:31 PM Flag

    why did these concerns surface now? we're one month further out from the last update with no reported safety issues and i think the company leaked good news on wed

    using mag's schedule, which is as good as anything we know or have, we're inside of one month of the trial being totally completed

    we'll know soon enuff

    Sentiment: Strong Buy

  • Reply to

    I need double helixx

    by macugen_rules Sep 5, 2014 6:14 PM
    vvvvvvrebel89130 vvvvvvrebel89130 Sep 5, 2014 10:03 PM Flag

    here's my concern

    is bergcyb an alias of yours?

    interesting timing now that "he" surfaces again

    Sentiment: Strong Buy

  • Reply to

    3422 trial timeline model

    by magnam_pi Sep 5, 2014 4:00 PM
    vvvvvvrebel89130 vvvvvvrebel89130 Sep 5, 2014 4:08 PM Flag

    so we're on line 21 or thereabouts; works for me; and as you say, no news is good news

    thanks for preparing and sharing

    Sentiment: Strong Buy

  • Reply to

    Critical Suport

    by macugen_rules Sep 5, 2014 1:39 PM
    vvvvvvrebel89130 vvvvvvrebel89130 Sep 5, 2014 3:02 PM Flag

    we won't

    Sentiment: Strong Buy

  • vvvvvvrebel89130 vvvvvvrebel89130 Sep 5, 2014 2:42 PM Flag

    there's been no more update and you know it; as binary pointed out, the update we posted is as of aug 7; it's the last word from the company; it's pretty safe to assume they're on track per magnum's timeline below

    1 month and as mag says, no news is good news

    if there was a safety issue they would have to report it immediately and that would kill the poc

    also, achn presented on wed at fbr conference in boston; at xactly 1015, est, stock ripped 60 pennies on 3 mm shrs; also, 990k shrs traded at $13.06 at the close; a big chunk of those were sold yesterday and rightfully so; spare me the "they can't release news at a conference" #$%$; i know that; firmly convinced that someone heard or saw something they really liked at the presentation; also, don't know the scheduled, but reasonable to assume that achn was talking to someone around that time

    • Sep 2, 2014 12:10 PM Flag

    2 users liked this posts users disliked this posts 0
    Reply

    I tried to model the 3422 trial timeline from the published protocol ... with time lags added for patient enrollment and lab tests ... from my model they have now completed 300 mg dosing of HCV patients and 500 mg dosing of healthy volunteers is in progress ... 500 mg dosing of HCV patients will start soon ... that's just from my model of course, so take it with a grain of salt ..

    Sentiment: Strong Buy

  • vvvvvvrebel89130 vvvvvvrebel89130 Sep 5, 2014 2:21 PM Flag

    wow, thats funny

    Sentiment: Strong Buy

  • vvvvvvrebel89130 vvvvvvrebel89130 Sep 5, 2014 2:18 PM Flag

    "We are very pleased with the continued progress being made with our HCV portfolio. In our Phase 1 trial of ACH-3422, a proprietary uridine-analog nucleotide inhibitor, we continue to evaluate escalating doses and to date have observed a good safety profile following 14 days of exposure with 50 mg and 150 mg in healthy subjects. We remain on track to report proof-of-concept results in the fall,"

    Sentiment: Strong Buy

  • vvvvvvrebel89130 by vvvvvvrebel89130 Sep 5, 2014 1:53 PM Flag

    14.00 ACHN141018C00014000 1.15 Down 0.85 1.10 1.25 6,971 297
    15.00 ACHN141018C00015000 0.90 Down 0.85 0.80 0.95 3,571 274

    Sentiment: Strong Buy

  • Reply to

    holy manipulation...

    by waiting4kerx Sep 5, 2014 1:48 PM
    vvvvvvrebel89130 vvvvvvrebel89130 Sep 5, 2014 1:48 PM Flag

    even when kerx wins, it loses

    this is mnkd all over again; craps out on approval

    Sentiment: Strong Buy

HPTX
26.105+0.725(+2.86%)2:44 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.